echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Osaicam Posaconazole Injection is about to pass the consistency evaluation

    Osaicam Posaconazole Injection is about to pass the consistency evaluation

    • Last Update: 2021-05-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, NMPA official website data shows that Osaikon’s posaconazole injection 3 types of imitation listing applications have entered the "under review" status, and it is expected to win the first domestic imitation + first review.


    Figure 1: Registration progress of Osaikon's posaconazole injection

    Source: NMPA official website

    Figure 2: Sales of posaconazole

    Source: Mi Nei.


    Posaconazole developed by Merck is a new generation of triazole antifungal drug with global sales of US$662 million in 2019.


    Table 1: Applications for imitation of posaconazole on the market

    Source: Meinenet MED2.


    Note: * is the enterprises included in the priority review

    In terms of domestic generic drugs, Shanghai Xuantai Pharmaceutical Technology's posaconazole enteric-coated tablets, which were declared and marketed in accordance with 4 types of generics, were contracted in February 2019, and were included in the priority review in September of the same year.


    If Osaikon successfully wins the first domestic imitation of posaconazole injection, it can form a combined attack with posaconazole enteric-coated tablets, and Merck’s monopoly of the market is expected to be broken.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.